Evidence map›Paper›PMID 27647852›Full record

Observational studyDiabetes care2016

Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes.

Jan Skupien, James H Warram, Adam M Smiles, Robert C Stanton, Andrzej S Krolewski

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Diabetes care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jan SkupienResearch Division, Joslin Diabetes Center, Boston, MA andrzej.krolewski@joslin.harvard.edu jan.skupien@uj.edu.pl.
James H WarramResearch Division, Joslin Diabetes Center, Boston, MA.
Adam M SmilesResearch Division, Joslin Diabetes Center, Boston, MA.
Robert C StantonResearch Division, Joslin Diabetes Center, Boston, MA.
Andrzej S KrolewskiResearch Division, Joslin Diabetes Center, Boston, MA andrzej.krolewski@joslin.harvard.edu jan.skupien@uj.edu.pl.
Joslin Diabetes Center · USHarvard University · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Tumor necrosis factor superfamily of ligands and receptors in progressive renal decline in diabetesR01DK041526 · NIDDK · JOSLIN DIABETES CENTER · PI KROLEWSKI, ANDRZEJ S · 1990 to 2018
$7.8M
NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK041526
6 · The paper itself

Abstract

objectiveThe patterns of estimated glomerular filtration rate (eGFR) decline to end-stage renal disease (ESRD) in patients with type 1 diabetes has not been conclusively described. Decline could be linearly progressive to ESRD but with a variable rate. Conversely, decline may be linear but interrupted by periods of plateaus or improvements. RESEARCH DESIGN AND

methodsThis observational study included 364 patients with type 1 diabetes attending the Joslin Clinic who developed ESRD between 1991 and 2013. We retrieved serum creatinine measurements from clinic visits or research examinations up to 24 years (median 6.7 years) preceding the onset of ESRD. Using serial measurements of serum creatinine to estimate renal function (eGFR), we used regression-based spline methods and a data smoothing approach to characterize individual trajectories of eGFR over time for the 257 patients with five or more data points.

resultsThe rate of eGFR decline per year ranged widely, from -72 to -2 mL/min/1.73 m

conclusionsThe decline of eGFR in type 1 diabetes is predominantly linear. Deviations from linearity are small, with little effect on the expected time of ESRD. A single disease process most likely underlies renal decline from its initiation and continues with the same intensity to ESRD. Linearity of renal decline suggests using slope reduction as the measure of effectiveness of interventions to postpone ESRD.

Indexed as

AdultDiabetes Mellitus, Type 1Diabetic NephropathiesDisease ProgressionFemaleGlomerular Filtration RateHumansKidneyKidney Failure, ChronicKidney Function TestsMaleMiddle AgedRenal Insufficiency, ChronicRisk Factors

Identifiers

PMID27647852
PMCPMC5127236
OpenAlexW2522735974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.